UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Validation of red flags in the workup of children with long‐term abdominal pain – A retrospective study

Acta Paediatrica, 2024-05, Vol.113 (5), p.1095-1102

2024

Volltextzugriff (PDF)

Immunological Effects of Adding Bovine Lactoferrin and Reducing Iron in Infant Formula: A Randomized Controlled Trial

Journal of pediatric gastroenterology and nutrition, 2022-03, Vol.74 (3), p.e65-e72

2022

Volltextzugriff (PDF)

Iron deficiency in infancy: current insights

Current opinion in clinical nutrition and metabolic care, 2021-05, Vol.24 (3), p.240-245

2021

Volltextzugriff (PDF)

Normal range and predictors of serum erythroferrone in infants

Pediatric research, 2023-09, Vol.94 (3), p.965-970

2023

Volltextzugriff (PDF)

Reduction of New Heterotopic Ossification (HO) in the Open‐Label, Phase 3 MOVE Trial of Palovarotene for Fibrodysplasia Ossificans Progressiva (FOP)

Journal of bone and mineral research, 2023-03, Vol.38 (3), p.381-394

2023

Volltextzugriff (PDF)

Maternal Obesity, Overweight and Gestational Diabetes Affect the Offspring Neurodevelopment at 6 and 18 Months of Age--A Follow Up from the PREOBE Cohort

PloS one, 2015-07, Vol.10 (7), p.e0133010-e0133010

2015

Volltextzugriff (PDF)

Cardiometabolic risk factors in children born with marginally low birth weight: A longitudinal cohort study up to 7 years-of-age

PloS one, 2019-04, Vol.14 (4), p.e0215866-e0215866

2019

Volltextzugriff (PDF)

Effects of iron supplementation of LBW infants on cognition and behavior at 3 years

Pediatrics (Evanston), 2013-01, Vol.131 (1), p.47-55

2013

Volltextzugriff (PDF)

Reducing Iron Content in Infant Formula from 8 to 2 mg/L Does Not Increase the Risk of Iron Deficiency at 4 or 6 Months of Age: A Randomized Controlled Trial

Nutrients, 2020-12, Vol.13 (1), p.3

2020

Volltextzugriff (PDF)

Vaccine response was higher in formula‐fed infants compared to breastfed but not affected by lactoferrin or iron in a randomised controlled trial

Acta Paediatrica, 2024-10, Vol.113 (10), p.2266-2274

2024

Volltextzugriff (PDF)

Visual evoked potentials in offspring born to mothers with overweight, obesity and gestational diabetes

PloS one, 2018-09, Vol.13 (9), p.e0203754-e0203754

2018

Volltextzugriff (PDF)

Hepcidin is a relevant iron status indicator in infancy: results from a randomized trial of early vs. delayed cord clamping

Pediatric research, 2021-04, Vol.89 (5), p.1216-1221

2021

Volltextzugriff (PDF)

Maternal, fetal and perinatal alterations associated with obesity, overweight and gestational diabetes: an observational cohort study (PREOBE)

BMC public health, 2016-03, Vol.16 (209), p.207-207, Article 207

2016

Volltextzugriff (PDF)

Effects of iron supplementation of low-birth-weight infants on cognition and behavior at 7 years: a randomized controlled trial

Pediatric research, 2018-01, Vol.83 (1), p.111-118

2018

Volltextzugriff (PDF)

Lower systolic blood pressure at age 7 y in low-birth-weight children who received iron supplements in infancy: results from a randomized controlled trial

The American journal of clinical nutrition, 2017-08, Vol.106 (2), p.475-480

2017

Volltextzugriff (PDF)

Overweight, Obesity, and Body Composition in 3.5- and 7-Year-Old Swedish Children Born with Marginally Low Birth Weight

The Journal of pediatrics, 2015-12, Vol.167 (6), p.1246-1252.e3

2015

Volltextzugriff (PDF)

Iron Supplementation Until 6 Months Protects Marginally Low‐Birth‐Weight Infants From Iron Deficiency During Their First Year of Life

Journal of pediatric gastroenterology and nutrition, 2015-03, Vol.60 (3), p.390-395

2015

Volltextzugriff (PDF)

The impacts of maternal iron deficiency and being overweight during pregnancy on neurodevelopment of the offspring

British journal of nutrition, 2017-10, Vol.118 (7), p.533-540

2017

Volltextzugriff (PDF)

Lower cognitive test scores at age 7 in children born with marginally low birth weight

Pediatric research, 2018-06, Vol.83 (6), p.1129-1135

2018

Volltextzugriff (PDF)

Serum hepcidin in infants born after 32 to 37 wk of gestational age

Pediatric research, 2016-04, Vol.79 (4), p.608-613

2016

Volltextzugriff (PDF)

Effects of Iron Supplementation on Auditory Brainstem Response in Marginally LBW Infants

Pediatric research, 2011-12, Vol.70 (6), p.601-606

2011

Volltextzugriff (PDF)

Effects of iron supplements and perinatal factors on fetal hemoglobin disappearance in LBW infants

Pediatric research, 2014-11, Vol.76 (5), p.477-482

2014

Volltextzugriff (PDF)

Marginally low birthweight increases the risk of underweight and short stature at three and a half years of age

Acta Paediatrica, 2016-06, Vol.105 (6), p.610-617

2016

Volltextzugriff (PDF)

Järntillskott bör ges till alla nyfödda med marginellt låg födelsevikt

Läkartidningen, 2012, Vol.109 (17-18), p.872

Berglund, Staffan K.

2012

Volltextzugriff (PDF)

The effects of palovarotene in patients with fibrodysplasia ossificans progressiva: a plain language summary

Future Rare Diseases, 2023, Vol.3 (1)

2023

Volltextzugriff (PDF)

1 – 25 von 93

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(84)
Mit Volltextzugriff
(78)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Validation of red flags in the workup of children with long‐term abdominal pain – A retrospective study

Immunological Effects of Adding Bovine Lactoferrin and Reducing Iron in Infant Formula: A Randomized Controlled Trial

Iron deficiency in infancy: current insights

Normal range and predictors of serum erythroferrone in infants

Reduction of New Heterotopic Ossification (HO) in the Open‐Label, Phase 3 MOVE Trial of Palovarotene for Fibrodysplasia Ossificans Progressiva (FOP)

Maternal Obesity, Overweight and Gestational Diabetes Affect the Offspring Neurodevelopment at 6 and 18 Months of Age--A Follow Up from the PREOBE Cohort

Cardiometabolic risk factors in children born with marginally low birth weight: A longitudinal cohort study up to 7 years-of-age

Effects of iron supplementation of LBW infants on cognition and behavior at 3 years

Reducing Iron Content in Infant Formula from 8 to 2 mg/L Does Not Increase the Risk of Iron Deficiency at 4 or 6 Months of Age: A Randomized Controlled Trial

Vaccine response was higher in formula‐fed infants compared to breastfed but not affected by lactoferrin or iron in a randomised controlled trial

Visual evoked potentials in offspring born to mothers with overweight, obesity and gestational diabetes

Hepcidin is a relevant iron status indicator in infancy: results from a randomized trial of early vs. delayed cord clamping

Maternal, fetal and perinatal alterations associated with obesity, overweight and gestational diabetes: an observational cohort study (PREOBE)

Effects of iron supplementation of low-birth-weight infants on cognition and behavior at 7 years: a randomized controlled trial

Lower systolic blood pressure at age 7 y in low-birth-weight children who received iron supplements in infancy: results from a randomized controlled trial

Overweight, Obesity, and Body Composition in 3.5- and 7-Year-Old Swedish Children Born with Marginally Low Birth Weight

Iron Supplementation Until 6 Months Protects Marginally Low‐Birth‐Weight Infants From Iron Deficiency During Their First Year of Life

The impacts of maternal iron deficiency and being overweight during pregnancy on neurodevelopment of the offspring

Lower cognitive test scores at age 7 in children born with marginally low birth weight

Serum hepcidin in infants born after 32 to 37 wk of gestational age

Effects of Iron Supplementation on Auditory Brainstem Response in Marginally LBW Infants

Effects of iron supplements and perinatal factors on fetal hemoglobin disappearance in LBW infants

Marginally low birthweight increases the risk of underweight and short stature at three and a half years of age

Järntillskott bör ges till alla nyfödda med marginellt låg födelsevikt

The effects of palovarotene in patients with fibrodysplasia ossificans progressiva: a plain language summary

Suchergebnisse filtern